Hazlett Burt & Watson Inc. Grows Stock Holdings in Astera Labs, Inc. $ALAB

Hazlett Burt & Watson Inc. grew its holdings in shares of Astera Labs, Inc. (NASDAQ:ALAB) by 97.5% in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,748 shares of the company’s stock after buying an additional 863 shares during the quarter. Hazlett Burt & Watson Inc.’s holdings in Astera Labs were worth $159,000 at the end of the most recent quarter.

Other hedge funds also recently made changes to their positions in the company. Fred Alger Management LLC raised its stake in shares of Astera Labs by 13.0% during the first quarter. Fred Alger Management LLC now owns 1,560,033 shares of the company’s stock valued at $93,087,000 after purchasing an additional 179,638 shares during the period. Hoey Investments Inc. raised its stake in shares of Astera Labs by 22.4% during the second quarter. Hoey Investments Inc. now owns 6,121 shares of the company’s stock valued at $553,000 after purchasing an additional 1,121 shares during the period. Wealth Effects LLC purchased a new stake in shares of Astera Labs during the second quarter valued at approximately $242,000. Realta Investment Advisors purchased a new stake in shares of Astera Labs during the second quarter valued at approximately $214,000. Finally, Sheets Smith Wealth Management purchased a new stake in shares of Astera Labs during the second quarter valued at approximately $481,000. Hedge funds and other institutional investors own 60.47% of the company’s stock.

Analyst Ratings Changes

A number of analysts have recently issued reports on the stock. Northland Capmk lowered shares of Astera Labs from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, July 22nd. Weiss Ratings reiterated a “hold (c-)” rating on shares of Astera Labs in a research note on Wednesday, October 8th. Jefferies Financial Group lifted their price objective on shares of Astera Labs from $95.00 to $130.00 and gave the company a “buy” rating in a research note on Tuesday, July 22nd. Zacks Research downgraded shares of Astera Labs from a “strong-buy” rating to a “hold” rating in a research report on Monday, October 6th. Finally, Stifel Nicolaus set a $145.00 price target on shares of Astera Labs and gave the stock a “buy” rating in a research note on Monday, August 4th. Fifteen investment analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the stock. According to data from MarketBeat.com, Astera Labs currently has an average rating of “Moderate Buy” and an average target price of $159.83.

Insider Activity at Astera Labs

In other Astera Labs news, CEO Jitendra Mohan sold 91,441 shares of the stock in a transaction on Monday, August 18th. The shares were sold at an average price of $183.51, for a total transaction of $16,780,337.91. Following the sale, the chief executive officer directly owned 2,170,877 shares of the company’s stock, valued at approximately $398,377,638.27. This represents a 4.04% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, General Counsel Philip Mazzara sold 10,000 shares of the stock in a transaction on Wednesday, October 1st. The stock was sold at an average price of $192.16, for a total transaction of $1,921,600.00. Following the sale, the general counsel directly owned 151,573 shares in the company, valued at $29,126,267.68. This trade represents a 6.19% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 1,308,772 shares of company stock valued at $214,482,678 in the last ninety days. 12.50% of the stock is owned by insiders.

Astera Labs Trading Down 3.2%

Shares of NASDAQ:ALAB opened at $199.53 on Tuesday. The company has a fifty day simple moving average of $199.95 and a 200 day simple moving average of $125.97. The firm has a market cap of $33.17 billion, a PE ratio of 356.30, a price-to-earnings-growth ratio of 5.14 and a beta of 1.43. Astera Labs, Inc. has a 12-month low of $47.13 and a 12-month high of $262.90.

Astera Labs (NASDAQ:ALAB) last issued its quarterly earnings results on Tuesday, August 5th. The company reported $0.44 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.33 by $0.11. Astera Labs had a net margin of 16.54% and a return on equity of 9.53%. The business had revenue of $191.93 million during the quarter, compared to analyst estimates of $172.46 million. During the same quarter in the previous year, the firm earned $0.13 earnings per share. The business’s revenue was up 149.5% compared to the same quarter last year. Astera Labs has set its Q3 2025 guidance at 0.380-0.390 EPS. As a group, equities research analysts forecast that Astera Labs, Inc. will post 0.34 EPS for the current fiscal year.

About Astera Labs

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.